BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17205128)

  • 1. IL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in patients affected by solid tumor.
    Roato I; Brunetti G; Gorassini E; Grano M; Colucci S; Bonello L; Buffoni L; Manfredi R; Ruffini E; Ottaviani D; Ciuffreda L; Mussa A; Ferracini R
    PLoS One; 2006 Dec; 1(1):e124. PubMed ID: 17205128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-7 modulates osteoclastogenesis in patients affected by solid tumors.
    Roato I; Gorassini E; Brunetti G; Grano M; Ciuffreda L; Mussa A; Ferracini R
    Ann N Y Acad Sci; 2007 Nov; 1117():377-84. PubMed ID: 17584976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoclasts are active in bone forming metastases of prostate cancer patients.
    Roato I; D'Amelio P; Gorassini E; Grimaldi A; Bonello L; Fiori C; Delsedime L; Tizzani A; De Libero A; Isaia G; Ferracini R
    PLoS One; 2008; 3(11):e3627. PubMed ID: 18978943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis.
    Colucci S; Brunetti G; Cantatore FP; Oranger A; Mori G; Quarta L; Cirulli N; Mancini L; Corrado A; Grassi FR; Grano M
    J Pathol; 2007 May; 212(1):47-55. PubMed ID: 17370327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement.
    Roato I; Grano M; Brunetti G; Colucci S; Mussa A; Bertetto O; Ferracini R
    FASEB J; 2005 Feb; 19(2):228-30. PubMed ID: 15550550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cells support osteoclastogenesis in an in vitro model derived from human periodontitis patients.
    Brunetti G; Colucci S; Pignataro P; Coricciati M; Mori G; Cirulli N; Zallone A; Grassi FR; Grano M
    J Periodontol; 2005 Oct; 76(10):1675-80. PubMed ID: 16253089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-7 production by B lymphocytes affects the T cell-dependent osteoclast formation in an in vitro model derived from human periodontitis patients.
    Colucci S; Mori G; Brunetti G; Coricciati M; Pignataro P; Oranger A; Cirulli N; Mastrangelo F; Grassi FR; Grano M
    Int J Immunopathol Pharmacol; 2005; 18(3 Suppl):13-9. PubMed ID: 16848983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone metastases in gastric cancer follow a RANKL-independent mechanism.
    D'Amico L; Satolli MA; Mecca C; Castiglione A; Ceccarelli M; D'Amelio P; Garino M; De Giuli M; Sandrucci S; Ferracini R; Roato I
    Oncol Rep; 2013 Apr; 29(4):1453-8. PubMed ID: 23404437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous osteoclastogenesis is a predictive factor for bone metastases from non-small cell lung cancer.
    Roato I; Gorassini E; Buffoni L; Lyberis P; Ruffini E; Bonello L; Baldi I; Ciuffreda L; Mussa A; Ferracini R
    Lung Cancer; 2008 Jul; 61(1):109-16. PubMed ID: 18061306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM; Nishioka K; Yudoh K
    Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes.
    Miranda-Carús ME; Benito-Miguel M; Balsa A; Cobo-Ibáñez T; Pérez de Ayala C; Pascual-Salcedo D; Martín-Mola E
    Arthritis Rheum; 2006 Apr; 54(4):1151-64. PubMed ID: 16575870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis.
    Sabokbar A; Kudo O; Athanasou NA
    J Orthop Res; 2003 Jan; 21(1):73-80. PubMed ID: 12507582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-18 inhibits TNF-alpha-induced osteoclastogenesis possibly via a T cell-independent mechanism in synergy with IL-12 in vivo.
    Morita Y; Kitaura H; Yoshimatsu M; Fujimura Y; Kohara H; Eguchi T; Yoshida N
    Calcif Tissue Int; 2010 Mar; 86(3):242-8. PubMed ID: 20111957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes.
    Kim YG; Lee CK; Oh JS; Kim SH; Kim KA; Yoo B
    Arthritis Rheum; 2010 Feb; 62(2):515-23. PubMed ID: 20112365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17 induces osteoclastogenesis from human monocytes alone in the absence of osteoblasts, which is potently inhibited by anti-TNF-alpha antibody: a novel mechanism of osteoclastogenesis by IL-17.
    Yago T; Nanke Y; Ichikawa N; Kobashigawa T; Mogi M; Kamatani N; Kotake S
    J Cell Biochem; 2009 Nov; 108(4):947-55. PubMed ID: 19728295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual modulation of osteoclast differentiation by lipopolysaccharide.
    Zou W; Bar-Shavit Z
    J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell-mediated increased osteoclast formation from peripheral blood as a mechanism for Crohn's disease-associated bone loss.
    Oostlander AE; Everts V; Schoenmaker T; Bravenboer N; van Vliet SJ; van Bodegraven AA; Lips P; de Vries TJ
    J Cell Biochem; 2012 Jan; 113(1):260-8. PubMed ID: 21898548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 inhibits TNF-α-mediated osteoclast formation by inhibition of RANKL expression in TNF-α-activated stromal cells and direct inhibition of TNF-α-activated osteoclast precursors via a T-cell-independent mechanism in vivo.
    Fujii T; Kitaura H; Kimura K; Hakami ZW; Takano-Yamamoto T
    Bone; 2012 Oct; 51(4):771-80. PubMed ID: 22776139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LIGHT (TNFSF14), a novel mediator of bone resorption, is elevated in rheumatoid arthritis.
    Edwards JR; Sun SG; Locklin R; Shipman CM; Adamopoulos IE; Athanasou NA; Sabokbar A
    Arthritis Rheum; 2006 May; 54(5):1451-62. PubMed ID: 16649193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.